ACG 2023 Conference Coverage


 

ACG 2023 Highlights: Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis at 8-16 Weeks: A Multicenter Retrospective Cohort Study

50 views
October 30, 2023
Comments 0
Login to view comments. Click here to Login